J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Classement en actions
#3880
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Prix de l'action
$26.58
Dernière synchronisation: 2026-07-23
Capitalisation boursière
$4.24B
Changement (1 jour)
0.00%
Changement (1 an)
38.19%
Pays
IN
Échange J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Catégorie
Healthcare
EPS pour J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
EPS au March 2026 TTM : $0.50
Selon les derniers rapports financiers et le cours de l'action de J. B. Chemicals & Pharmaceuticals Limited, l’EPS actuel de la société (TTM) est de $0.50. À la fin de 2024, la société avait un EPS de $0.43 une augmentation par rapport à celui de 2023, qui était de $0.32.
Historique de l'EPS de J. B. Chemicals & Pharmaceuticals Limited de 2005 à 2026
EPS à la fin de chaque année
| Année | EPS | Changez |
|---|---|---|
| 2026 (TTM) | $0.50 | -0.14% |
| 2025 | $0.50 | 16.04% |
| 2024 | $0.43 | 32.62% |
| 2023 | $0.32 | -1.80% |
| 2022 | $0.33 | -17.05% |
| 2021 | $0.40 | -13.65% |
| 2020 | $0.46 | 35.25% |
| 2019 | $0.34 | 33.94% |
| 2018 | $0.25 | -24.36% |
| 2017 | $0.33 | 15.70% |
| 2016 | $0.29 | 52.45% |
| 2015 | $0.19 | 56.65% |
| 2014 | $0.12 | -29.84% |
| 2013 | $0.17 | -89.07% |
| 2012 | $1.58 | 326.74% |
| 2011 | $0.37 | 18.09% |
| 2010 | $0.31 | 421.63% |
| 2009 | $0.06 | -55.22% |
| 2008 | $0.13 | -21.29% |
| 2007 | $0.17 | -13.10% |
| 2006 | $0.20 | 17.98% |
| 2005 | $0.17 | 0.00% |
EPS pour des entreprises ou concurrents similaires
| Entreprise | EPS | Différence d’EPS | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 11.42% |
IN
|
